Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-GDF15 antibody and a dosage regimen for the treatment of cancer

Anti-GDF15 antibody and a dosage regimen for the treatment of cancer

US Patent 12497447 · Granted Dec 16, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

GDF-15 as a diagnostic marker to predict the clinical outcome of a treatment wit2025
GDF-15 as a diagnostic marker to predict the clinical outcome of a treatment wit2025
Monoclonal antibodies to growth and differentiation factor 15 (GDF-15)2024
Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses2023
Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses2023
Combination therapy using inhibitors of human growth and differentiation factor 2022
Combination therapy using inhibitors of human growth and differentiation factor 2022
GDF-15 as a diagnostic marker to predict the clinical outcome of a treatment wit2022
GDF-15 as a diagnostic marker to predict the clinical outcome of a treatment wit2022
TGF-beta oligonucleotide for use in treatment of ophthalmic diseases2021
Means and methods for the treament of B cell non-hodgkin lymphoma and B cell leu2021
Monoclonal antibodies to growth and differentiation factor 15 (GDF-15)2020